Van Ness BG - Search Results

1

Prognostic significance of the S-phase fraction of light-chain-restricted cytoplasmic immunoglobulin (cIg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486.

Trendle MC, Leong T, Kyle RA, Katzmann JA, Oken MM, Kay NE, Van Ness BG, Greipp PR. Trendle MC, et al. Among authors: van ness bg. Am J Hematol. 1999 Aug;61(4):232-7. doi: 10.1002/(sici)1096-8652(199908)61:4<232::aid-ajh2>3.0.co;2-t. Am J Hematol. 1999. PMID: 10440908 Free article.

2

Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients.

Billadeau D, Quam L, Thomas W, Kay N, Greipp P, Kyle R, Oken MM, Van Ness B. Billadeau D, et al. Blood. 1992 Oct 1;80(7):1818-24. Blood. 1992. PMID: 1391945 Free article.

3

B-chronic lymphocytic leukemia cells contain both endogenous kappa immunoglobulin mRNA and critical immunoglobulin gene activation transcription factors.

Zaknoen SL, Christian SL, Suen R, Van Ness B, Kay NE. Zaknoen SL, et al. Leukemia. 1992 Jul;6(7):675-9. Leukemia. 1992. PMID: 1625486

4

Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease.

Billadeau D, Blackstadt M, Greipp P, Kyle RA, Oken MM, Kay N, Van Ness B. Billadeau D, et al. Blood. 1991 Dec 1;78(11):3021-9. Blood. 1991. PMID: 1954387 Free article.

5

Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study Group.

Kay NE, Oken MM, Bone N, Kyle RA, Greipp P, Van Ness B, Leong T. Kay NE, et al. Blood. 1995 Nov 15;86(10):4000-1. Blood. 1995. PMID: 7579374 Free article. No abstract available.

6

Sequential phenotyping of myeloma patients on chemotherapy: persistence of activated T-cells and natural killer cells.

Kay NE, Oken MM, Kyle R, Van Ness B, Kalish L, Leong T, Greipp P. Kay NE, et al. Leuk Lymphoma. 1995 Jan;16(3-4):351-4. doi: 10.3109/10428199509049775. Leuk Lymphoma. 1995. PMID: 7719242 Clinical Trial.

7

Detection of B-cells clonally related to the tumor population in multiple myeloma and MGUS.

Billadeau D, Greipp P, Ahmann G, Witzig T, Van Ness B. Billadeau D, et al. Curr Top Microbiol Immunol. 1995;194:9-16. doi: 10.1007/978-3-642-79275-5_2. Curr Top Microbiol Immunol. 1995. PMID: 7895525 No abstract available.

8

The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.

Billadeau D, Ahmann G, Greipp P, Van Ness B. Billadeau D, et al. J Exp Med. 1993 Sep 1;178(3):1023-31. doi: 10.1084/jem.178.3.1023. J Exp Med. 1993. PMID: 8350044 Free PMC article.

9

Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma.

Billadeau D, Van Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, Witzig TE. Billadeau D, et al. Blood. 1996 Jul 1;88(1):289-96. Blood. 1996. PMID: 8704185 Free article.

10

Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial.

Liu P, Leong T, Quam L, Billadeau D, Kay NE, Greipp P, Kyle RA, Oken MM, Van Ness B. Liu P, et al. Blood. 1996 Oct 1;88(7):2699-706. Blood. 1996. PMID: 8839865 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters